TITLE

Intl Stem Cell Corp Announces 3rd Qtr 2011 Financial Results

PUB. DATE
November 2011
SOURCE
Biomedical Market Newsletter;11/21/2011, Vol. 21, p789
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the 2011 third quarter financial performance of International Stem Cell Corp. (ISCO) which declares a revenue of 0.84 million dollars for the quarter. It states that increases in revenue was strongly motivated by strong sales from the initial launch of ISCO's wholly-owned subsidiary Lifeline Skin Care (LSC) and Lifeline Cell Technology (LCT). According to chief executive officer (CEO) Andrey Semechkin, sales in LSC and LCT provide the needed capital to help support growth.
ACCESSION #
69634040

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics